The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice
Arthritis & Rheumatology · 2024
DOI: 10.1002/art.42930 ↗Kurz gefasst
Editorial in der Zeitschrift Arthritis & Rheumatology, 2024. Verfasst von Jinoos Yazdany und 2 weiteren Autor:innen. Beteiligte Einrichtung: University of California, San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, California. Hauptthemen laut MEDLINE: Hydroxychloroquine, Antirheumatic Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California, San Francisco and Zuckerberg San Francisco General Hospital, San Francisco, California.
- University of California, San Francisco.
- University of California, San Francisco and San Francisco Veterans Affairs Medical Center, San Francisco, California.
ORCID-Profile: Jinoos Yazdany, Gabriela Schmajuk
Zitieren
APA
Yazdany, J., Shiboski, S., & Schmajuk, G. (2024). The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice. Arthritis & Rheumatology. https://doi.org/10.1002/art.42930
Vancouver
Yazdany J, Shiboski S, Schmajuk G. The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice. Arthritis & Rheumatology. 2024. doi:10.1002/art.42930
BibTeX
@article{Yazdany2024,
author = {Yazdany, Jinoos and Shiboski, Stephen and Schmajuk, Gabriela},
title = {The Hydroxychloroquine Conundrum: Striking the Right Balance Between Safety and Efficacy in Rheumatology Practice},
journal = {Arthritis & Rheumatology},
year = {2024},
doi = {10.1002/art.42930}
}
EUVIMED